Coronary heart disease
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Regulatory Factor X1 Downregulation Contributes to Monocyte Chemoattractant Protein-1 Overexpression in CD14+ Monocytes <i>via</i> Epigenetic Mechanisms in Coronary Heart Disease.
|
31737059 |
2019 |
Coronary heart disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Association of COL4A1 (rs605143, rs565470) and CD14 (rs2569190) genes polymorphism with coronary artery disease.
|
29299748 |
2018 |
Coronary heart disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Impact of CD14 Polymorphisms on Anti-Apolipoprotein A-1 IgG-Related Coronary Artery Disease Prediction in the General Population.
|
29074586 |
2017 |
Coronary heart disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
The number of circulating CD14(+)CD16(+) monocytes is increased in patients with chronic renal failure or coronary artery disease.
|
25134759 |
2015 |
Coronary heart disease
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Moreover, we observed that the level of miR-155 expression was up-regulated in CD14(+) monocytes from patients with coronary heart disease.
|
24675724 |
2014 |
Coronary heart disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
In conclusion, our results indicate that the CD14 C-260T polymorphism is a risk factor of CHD, especially in East Asians.
|
23277403 |
2013 |
Coronary heart disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
This study evaluated associations between clinical oral health status, CD14 polymorphisms, and CHD.
|
23146639 |
2012 |
Coronary heart disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
CRP and CD14 polymorphisms correlate with coronary plaque volume in patients with coronary artery disease--IVUS substudy of the ENCORE trials.
|
22056216 |
2012 |
Coronary heart disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Role of the CD14 C(-260)T promoter polymorphism in determining the first clinical manifestation of coronary artery disease.
|
19829130 |
2010 |
Coronary heart disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
CD14 promoter polymorphism (- 159C-->t) is not associated with myocardial infarction or coronary artery disease in patients with assumed high genetic risk.
|
19795323 |
2009 |
Coronary heart disease
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
We investigated mRNA expression levels using reverse transcription-polymerase chain reaction of genes involved in cholesterol uptake (macrophage scavenger receptor (MSR1), scavenger receptor class B member 1 (SRB1), lectin-like oxidized low-density lipoprotein (LDL) receptor 1 (LOX1), CD36, LDL receptor (LDLR)), reverse cholesterol transport (apolipoprotein E (ApoE), ATP-binding cassette sub-family A member 1 (ABCA1)) and inflammation (tumour necrosis factor-alpha (TNF-alpha), macrophage inflammatory protein-1alpha (MIP-1alpha), interleukin-6 (IL-6), tissue factor) in CD14(+) monocytes from 119 consecutively recruited patients and found that median CD36 mRNA expression levels were significantly increased in patients with CHD compared with controls (111 x 10(3) vs 96 x 10(3) copies/10(6) copies beta-actin, respectively; n = 79 and 40, respectively; P < 0.05), despite a high interindividual variability in gene expression.3.
|
18067591 |
2008 |
Coronary heart disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
CD14 gene polymorphism 159C/T in a group of patients with coronary artery disease from a population with high morbidity of cardiovascular diseases.
|
17436151 |
2007 |
Coronary heart disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Post-hoc analysis on the CD14 C(-260)T promoter polymorphism and coronary heart disease.
|
17087609 |
2007 |
Coronary heart disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
A functional polymorphism in the promoter of the CD14 gene (CD14 C-260T) was associated with coronary heart disease and atherosclerosis albeit with conflicting data.
|
17098305 |
2007 |
Coronary heart disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Influence of the CD14 C260T promoter polymorphism on C-reactive protein levels in patients with coronary artery disease.
|
17056323 |
2006 |
Coronary heart disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
A common C-260T polymorphism in the promoter of the CD14 gene, the trans-membrane receptor of lipopolysaccharides, has been inconsistently associated with coronary heart disease.
|
15777548 |
2005 |
Coronary heart disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The TLR4/Asp299Gly and CD14/C-260T polymorphisms and plasma sCD14 concentrations do not appear as significant predictors of the risk of CHD in healthy individuals.
|
15367917 |
2004 |
Coronary heart disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
It has been recently shown that a C(-260)T polymorphism in the promoter of the CD14 receptor may be a risk factor for coronary artery disease.
|
14648231 |
2003 |
Coronary heart disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
CD14 gene -159C/T polymorphism is not associated with coronary artery disease and myocardial infarction.
|
12075251 |
2002 |
Coronary heart disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Recently, a polymorphism in the promotor of the CD14 gene, C (-260) T, was detected as a risk factor for coronary heart disease.
|
12140663 |
2002 |
Coronary heart disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
CD14 C(-260)-->T polymorphism, plasma levels of the soluble endotoxin receptor CD14, their association with chronic infections and risk of stable coronary artery disease.
|
12103253 |
2002 |
Coronary heart disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
In this study, LPS receptor CD14 was analyzed to find genetic variants and check them for an association with coronary artery disease or myocardial infarction (MI).
|
10195920 |
1999 |